Oxford Nanopore Technologies plc PDMR/PCA Notification

RNS Number : 6795R

Oxford Nanopore Technologies plc

07 June 2024

 

7 June 2024

Oxford Nanopore Technologies plc

(the "Company")

PDMR/PCA Notification

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

The Company has been notified that, on 7 June 2024, Jacob Henry Cowper, a Person Closely Associated with Timothy Cowper, Chief Operating Officer of the Company and a Person Discharging Managerial Responsibilities, purchased a total of 10,000 ordinary shares in the Company at a price of £1.034667 per share.

This announcement is made pursuant to the Company's obligations under Article 19 of the UK Market Abuse Regulation.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Jacob Henry Cowper
2	Reason for the notification
a)	Position/status	Person Closely Associated with Timothy Cowper, Chief Operating Officer
b)	Initial/Amendment notification	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Oxford Nanopore Technologies plc
b)	LEI	213800IRWQ2Q6M2CDW55
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument   Identification code	Ordinary shares of £0.0001 each     GB00BP6S8Z30
b)	Nature of the transaction	Purchase of shares in the Company
c)	Price(s) and volume(s)	Price(s) Volume(s) £1.034667 10,000
d)	Aggregated information - Aggregated volume  - Aggregated price	10,000 £10,346.67
e)	Date of the transaction	7 June 2024
f)	Place of the transaction	London Stock Exchange (XLON)

[ENDS]

Enquiries:

Investors

[e-mail] 

Media 

[e-mail]

[e-mail]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

DSHUBVSRSSUNRAR